Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12229995rdf:typepubmed:Citationlld:pubmed
pubmed-article:12229995lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:12229995lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:12229995lifeskim:mentionsumls-concept:C0681916lld:lifeskim
pubmed-article:12229995lifeskim:mentionsumls-concept:C0750572lld:lifeskim
pubmed-article:12229995lifeskim:mentionsumls-concept:C0679201lld:lifeskim
pubmed-article:12229995lifeskim:mentionsumls-concept:C0680844lld:lifeskim
pubmed-article:12229995lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:12229995pubmed:issue3lld:pubmed
pubmed-article:12229995pubmed:dateCreated2002-9-16lld:pubmed
pubmed-article:12229995pubmed:abstractTextThis article is motivated by an application where subjects were dosed three times with the same drug and the drug concentration profiles appeared to be the lowest after the third dose. One possible explanation is that the pharmacokinetic (PK) parameters vary over time. Therefore, we consider population PK models with time-varying PK parameters. These time-varying PK parameters are modeled by natural cubic spline functions in the ordinary differential equations. Mean parameters, variance components, and smoothing parameters are jointly estimated by maximizing the double penalized log likelihood. Mean functions and their derivatives are obtained by the numerical solution of ordinary differential equations. The interpretation of PK parameters in the model and its flexibility are discussed. The proposed methods are illustrated by application to the data that motivated this article. The model's performance is evaluated through simulation.lld:pubmed
pubmed-article:12229995pubmed:languageenglld:pubmed
pubmed-article:12229995pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12229995pubmed:citationSubsetIMlld:pubmed
pubmed-article:12229995pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12229995pubmed:statusMEDLINElld:pubmed
pubmed-article:12229995pubmed:monthSeplld:pubmed
pubmed-article:12229995pubmed:issn0006-341Xlld:pubmed
pubmed-article:12229995pubmed:authorpubmed-author:GuptaSuneelSlld:pubmed
pubmed-article:12229995pubmed:authorpubmed-author:BrownMorton...lld:pubmed
pubmed-article:12229995pubmed:authorpubmed-author:LiLangLlld:pubmed
pubmed-article:12229995pubmed:authorpubmed-author:LeeKyung-Hoon...lld:pubmed
pubmed-article:12229995pubmed:issnTypePrintlld:pubmed
pubmed-article:12229995pubmed:volume58lld:pubmed
pubmed-article:12229995pubmed:ownerNLMlld:pubmed
pubmed-article:12229995pubmed:authorsCompleteYlld:pubmed
pubmed-article:12229995pubmed:pagination601-11lld:pubmed
pubmed-article:12229995pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:meshHeadingpubmed-meshheading:12229995...lld:pubmed
pubmed-article:12229995pubmed:year2002lld:pubmed
pubmed-article:12229995pubmed:articleTitleEstimation and inference for a spline-enhanced population pharmacokinetic model.lld:pubmed
pubmed-article:12229995pubmed:affiliationDivision of Biostatistics, Indiana University, Indianapolis 46202, USA. lali@iupui.edulld:pubmed
pubmed-article:12229995pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12229995pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12229995lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12229995lld:pubmed